Express News | ACELYRIN Shares Down 6.5% After Co Reiterates Merger With Alumis

ReutersMar 4 11:14 ET

Express News | Refile-Buzz-ACELYRIN Slides After Reiterating Merger With Alumis Amid Concentra's Buyout Offer

ReutersMar 4 10:31 ET

Acelyrin Falls as Acelyrin Reaffirms Deal Commitment

Seeking AlphaMar 4 09:37 ET

Acelyrin Says Concentra Indication Not Expected to Result in Superior Proposal

TipRanksMar 4 09:12 ET

Acelyrin and Alumis: Combined Company to Benefit From Differentiated Late-Stage Portfolio of Therapies and Strong Balance Sheet

Dow JonesMar 4 09:03 ET

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

GlobeNewswireMar 4 09:01 ET

Press Release: ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

Dow JonesMar 4 09:01 ET

Press Release: Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger

Dow JonesMar 4 09:01 ET

Top-rated Biotechs With Negative Enterprise Values

Seeking AlphaMar 1 14:28 ET

Key Deals This Week: Howard Hughes, Shift4 Payments, Herc Holdings, Celsius and More

Seeking AlphaFeb 22 15:35 ET

Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal

Stocks TelegraphFeb 21 11:04 ET

Acelyrin Stock Jumps on Concentra Acquisition Interest

WSJFeb 21 09:16 ET

Reported Earlier, ACELYRIN Confirms Unsolicited $3/Share Offer From Concentra Biosciences Amid Pending Alumis Merger

BenzingaFeb 21 01:18 ET

Express News | ACELYRIN Confirms Receipt of Unsolicited Indication of Interest From Concentra Biosciences

ReutersFeb 20 21:01 ET

Express News | Tang Capital Management Reports 5.3% Stake in ACELYRIN as of 18TH Feb- SEC Filing

ReutersFeb 20 18:28 ET

Express News | Tang Capital Management: On Behalf of Concentra Biosciences Submit Non-Binding Proposal to Acquire ACELYRIN for $3.00 per Share

ReutersFeb 20 18:27 ET

Alumis And ACELYRIN's Merger Marks A New Era For Late-Stage Biopharma Advancements

RTTNewsFeb 7 10:57 ET

Alumis and Acelyrin Sign Merger Agreement

Yahoo FinanceFeb 7 10:44 ET

Wells Fargo Maintains Acelyrin(SLRN.US) With Buy Rating

Moomoo NewsFeb 7 07:33 ET · Ratings

Piper Sandler Sticks to Their Buy Rating for ACELYRIN, INC. (SLRN)

TipRanksFeb 7 06:50 ET · Ratings